Cite
HARVARD Citation
DeAngelo, D. et al. (n.d.). Phase II trial of panobinostat, an oral pan‐deacetylase inhibitor in patients with primary myelofibrosis, post–essential thrombocythaemia, and post–polycythaemia vera myelofibrosis. British journal of haematology. pp. 326-335. [Online].